Aclidinium, a dual-action compound, serves as a long-acting muscarinic antagonist and a beta2-adrenoceptor (beta2-AR) agonist, exhibiting bronchodilator properties. It effectively reduces lung hyperinflation, enhances lung function, and prolongs exercise endurance time. This compound is commonly utilized in studies focusing on chronic obstructive pulmonary disease (COPD).
Molekulargewicht:
484.65
CAS Nummer:
[727649-81-2]
Formel:
C26H30NO4S2
Target-Kategorie:
Adrenergic Receptor
T200043
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
